Clinical Trial Update: Efficacy and Safety of Aliskiren and Valsartan Versus Placebo in Patients Stabilized Following an Acute Coronary Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of aliskiren plus valsartan versus placebo in patients stabilized after an acute coronary syndrome, with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Myocardial Ischemia

Drugs mentioned

• DIOVAN (valsartan)
• Tekturna (aliskiren)

Snippet

Sponsor: Novartis | Conditions: Post Acute Coronary Syndrome, Myocardial Ischemia | Phase 2 | Status: COMPLETED | Results posted: 2011-02-02